Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children
GloVitAS-P
2 other identifiers
observational
123
1 country
1
Brief Summary
The goal of this study is to assess whether children 12-18 months of age who are exposed to multiple large-scale vitamin A programs, and who are likely to have vitamin A intakes above the tolerable upper intake level (UL), have higher total body vitamin A stores and biomarkers of excessive vitamin A status, compared to children 12-18 months of age who have adequate vitamin A intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 17, 2017
CompletedFirst Posted
Study publicly available on registry
January 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedMay 4, 2017
May 1, 2017
7 months
January 17, 2017
May 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Total body vitamin A stores among children 12-18 mo of age
Estimated using the 13C-retinol dilution method
28-day study period
Total dietary vitamin A intake among children 12-18 mo of age
Estimated using 24-hour dietary recalls, observed weighed food records, food and supplement frequency questionnaire, breast milk vitamin A concentration, and total breast milk intake (measured by the dose-to-mother deuterium dilution technique)
28-day study period
Total breast milk intake (among breastfeeding children 12-18 mo of age)
Estimating using the dose-to-mother deuterium dilution technique.
15-day study period
Secondary Outcomes (11)
Plasma or serum retinol among children 12-18 mo of age
28-day study period
Plasma or serum retinol-binding protein among children 12-18 mo of age
28-day study period
Ratio of retinol to retinol-binding protein among children 12-18 mo of age
28-day study period
Retinol metabolites among children 12-18 mo of age
28-day study period
Transthyretin among children 12-18 mo of age
28-day study period
- +6 more secondary outcomes
Other Outcomes (11)
Total food and nutrient intakes among women
28-day study period and 30 days prior to study period
Total food and nutrient intakes among children
28-day study period and 30 days prior to study period
Infant weight-for-length z score
At recruitment
- +8 more other outcomes
Study Arms (3)
Group 1: High VA intake, recent VAS
Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (VAS; 200,000 IU) in the past month, and are identified as being likely to have chronic excessive dietary VA intake
Group 2: High VA intake
Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (200,000 IU) in the past 3-6 months, and are identified as being likely to have chronic excessive dietary VA intake.
Group 3: Low/adequate VA intake
Children who are not exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement in the past 3-6 months, and are identified as being likely to have chronic low to adequate dietary VA intake.
Interventions
Children who are exposed to multiple VA programs, have received a high-dose VA supplement (VAS; 200,000 IU) in the past month, and are identified as being likely to have chronic excessive dietary VA intake.
Children who are exposed to multiple VA programs, have received a high-dose VA supplement (200,000 IU) in the past 3-6 months, and are identified as being likely to have chronic excessive dietary VA intake.
Children who are not exposed to multiple VA programs, have received a high-dose VA supplement in the past 3-6 months, and are identified as being likely to have chronic low to adequate dietary VA intake.
Eligibility Criteria
Children 12-18 months of age and their mothers in selected neighborhoods in the National Capital Region of the Philippines
You may qualify if:
- Children 12-18 months of age, and their mothers (18-49 years of age)
- Living in selected communities in the National Capital Region of the Philippines
- The mother and child must plan to stay in the study area for the duration of the study.
- Child's estimated vitamin A intake and exposure to vitamin A programs must meet eligibility criteria for one of three groups, based on a screening questionnaire administered by an interviewer to the child's mother.
- Eligibility criteria for children in Group 1: 1) consumed MNP or a multi-vitamin preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule during the previous month, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
- Eligibility criteria for children in Group 2: will include children who: 1) consumed MNP or a multi-vitamin A preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule in the previous 3-6 months, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
- Eligibility criteria for children in Group 3: will include children who: 1) received a high dose VA capsule during the previous 3-6 months, and 2) received a screening tool 'score' suggesting VA intake 200-500 µg/d.
You may not qualify if:
- The child did not receive a high-dose VA capsule during the most recent national campaign
- The mother or child has chronic disease
- The child has moderate or severe anemia (Hb \<10 g/dL)
- The mother or child has signs or symptoms of vitamin A deficiency (Bitot's spots, conjunctival xerosis, nightblindness)
- The child has weight for length \< -2 z-scores of the median of the WHO growth standards
- The mother is breastfeeding more than one child
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- Newcastle Universitycollaborator
- Penn State Universitycollaborator
- Helen Keller Internationalcollaborator
- Food and Nutrition Research Institute, Philippinescollaborator
- Global Alliance for Improved Nutritioncollaborator
- Bill and Melinda Gates Foundationcollaborator
- International Atomic Energy Agencycollaborator
Study Sites (1)
Block 37 Health Center
Mandaluyong, National Capital Region, Philippines
Related Publications (3)
Engle-Stone R, Miller JC, Reario MFD, Arnold CD, Stormer A, Lafuente E, Oxley A, Capanzana MV, Cabanilla CVD, Ford JL, Clark A, Velavan TP, Brown KH, Lietz G, Haskell MJ. Filipino Children with High Usual Vitamin A Intakes and Exposure to Multiple Sources of Vitamin A Have Elevated Total Body Stores of Vitamin A But Do Not Show Clear Evidence of Vitamin A Toxicity. Curr Dev Nutr. 2022 Jul 25;6(8):nzac115. doi: 10.1093/cdn/nzac115. eCollection 2022 Aug.
PMID: 36060221DERIVEDOxley A, Engle-Stone R, Miller JC, Reario MFD, Stormer A, Capanzana MV, Cabanilla CVD, Haskell MJ, Lietz G. Determination of Vitamin A Total Body Stores in Children from Dried Serum Spots: Application in a Low- and Middle-Income Country Community Setting. J Nutr. 2021 May 11;151(5):1341-1346. doi: 10.1093/jn/nxaa446.
PMID: 33755155DERIVEDFord JL, Green JB, Haskell MJ, Ahmad SM, Mazariegos Cordero DI, Oxley A, Engle-Stone R, Lietz G, Green MH. Use of Model-Based Compartmental Analysis and a Super-Child Design to Study Whole-Body Retinol Kinetics and Vitamin A Total Body Stores in Children from 3 Lower-Income Countries. J Nutr. 2020 Feb 1;150(2):411-418. doi: 10.1093/jn/nxz225.
PMID: 31535129DERIVED
Biospecimen
Serum, plasma, red and white cells, dried blood spots, breast milk
Study Officials
- STUDY DIRECTOR
Georg Lietz
Newcastle University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2017
First Posted
January 25, 2017
Study Start
August 1, 2016
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
May 4, 2017
Record last verified: 2017-05